While much remains to be understood about the precise mechanisms by which cGAS-STING contributes to neurodegeneration, the development of inhibitors targeting this pathway has already demonstrated preclinical success in alleviating neuroinflammation and pathology in dementia animal models. This evidence concerns the gene STING1 and dementia.